Psoriatic arthritis. Is something changing?
The definition of psoriatic arthritis may be at least inadequate. Moreover, diagnostic criteria proposed may be too restrictive. This may have affected the collection of reliable epidemiological data and may also influenced the classification of the disease. In this article all these aspects are discussed with the aim of offering an up-date on this intriguing disease. Therapeutic options are also examined.
Scarpa
R
R
Department of Internal Medicine, University Federico II, Naples, Italy.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000209:etiology; D015535:Arthritis, Psoriatic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D016572:Cyclosporine / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000209:etiology; D012460:Sulfasalazine / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D012460:Sulfasalazine; D006046:Gold; D016572:Cyclosporine; D008727:Methotrexate